U.S. health experts on December 30 urged Americans to prepare for severe disruptions in coming weeks as the rising wave of COVID-19 cases led by the Omicron variant threatened hospitals, schools and other sectors impacting their daily lives.
Americans vaccinated and boosted against COVID-19 can be with family over the holidays but attending large gatherings is not safe, even for those who received a booster dose, top U.S. infectious disease expert Anthony Fauci said on December 22.
COVID-19 vaccine makers have contingency plans to deal with the Omicron variant that include a combination vaccine against the original version and the variant as well as a variant-specific booster dose, a top U.S. health official said on December 3.
Vaccines for kids between the ages of 5 and 11 will likely be available in the first half of November, top U.S. infectious disease expert Anthony Fauci said on Oct. 24, predicting a timetable that could see many kids getting fully vaccinated before the end of 2021.
Americans can choose a Covid-19 booster shot that is different from their original inoculation but the recommendation is to stick with the vaccine they got first if available, White House chief medical adviser Dr. Anthony Fauci said on Oct. 22.
In October 2020, the government recommended against kids going trick-or-treating for Halloween out of fear of Covid-19 spread. For Halloween 2021, kids have been given the green light to knock on doors.
COVID-19 Update: J&J to Request Booster Authorization, Merck Antiviral Review a Priority
Antivirals, BioNTech, BNT162b2 (Pfizer and BioNTech), Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Antibodies, COVID-19 booster shots, COVID-19 Deaths, COVID-19 Vaccines, Dr. Anthony Fauci (Director), Molnupiravir, R&D, Scripps Research InstituteJohnson & Johnson is expected to ask the U.S. Food and Drug Administration to authorize a booster for the company’s one-shot Covid-19 vaccine this week. In other news, President Biden’s chief medical advisor Dr. Anthony Fauci told CNBC that they expect the FDA to review data on Merck and Ridgeback Biotherapeutics’ new oral antiviral against Covid-19 “as quickly as they possibly can.”
Key data on U.S. J&J, Moderna COVID-19 boosters weeks away, Fauci says
BNT162b2 (Pfizer and BioNTech), COVID-19 booster shots, COVID-19 cases, Covid-19 Data, Dr. Anthony Fauci (Director), FDA, Health Officials, Janssen COVID-19 Vaccine (J&J), Kids, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), National Institute of Allergy and Infectious Diseases (NIAID)Data needed to determine the advisability of booster shots of the Moderna Inc. and Johnson & Johnson Covid-19 vaccines is just weeks away, President Joe Biden’s chief medical adviser, Dr. Anthony Fauci, said on Sept. 19.
President Joe Biden on Sept. 9 will present a six-pronged strategy intended to fight the spread of the highly contagious coronavirus Delta variant and increase U.S. Covid-19 vaccinations, the White House said on Sept. 7.
Delta Remains Largest Concern as COVID-19 Cases Increased 316% in the Last Year
B.1.621 or “Mu” variant (Colombia), Blood Samples, COVID-19 Antibodies, COVID-19 Deaths, COVID-19 Infections, COVID-19 Studies, Delta Variant (B.1.617.2; India), Department of Health and Human Services (HHS), Dr. Anthony Fauci (Director), First Responders, Johns Hopkins Universit, Los Angeles, University of Pennsylvania (Penn)Data from Johns Hopkins University demonstrate that daily Covid-19 infections increased 316 percent from Labor Day 2020, or about four times more.